₨ NPR
Description
Telvas-H 40/12.5mg Tablets combine telmisartan and hydrochlorothiazide to treat hypertension. Telmisartan, an angiotensin II receptor blocker, relaxes blood vessels, while hydrochlorothiazide, a diuretic, reduces fluid retention, lowering blood pressure. The tablets are taken orally, usually once daily, with or without food. Telvas-H is effective for patients requiring combination therapy to control high blood pressure and reduce cardiovascular risks. It requires a prescription and regular monitoring for side effects like electrolyte imbalance or kidney function changes. Store in a cool, dry place, and follow the prescribed regimen to ensure efficacy.
Uses:
– Manages essential hypertension in adults.
– Reduces risk of stroke or heart attack in high-risk patients.
– Controls blood pressure in combination therapy.
– Supports kidney health in hypertensive patients.
Precautions:
– Monitor potassium levels to avoid hyperkalemia.
– Avoid in pregnancy due to potential fetal harm.
– Use cautiously in patients with kidney or liver impairment.
– Discontinue if severe dizziness or dehydration occurs.
Store in a cool, dry place below 30°C, away from moisture. Keep out of reach of children. Prescription required.
Reviews
There are no reviews yet.